These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay. Hosotsubo H, Takahara S, Imamura R, Kyakuno M, Tanaka T, Yazawa K, Hanafusa T, Matsumiya K, Nonomura N, Okuyama A, Sugimoto H. Ther Drug Monit; 2001 Dec; 23(6):669-74. PubMed ID: 11802102 [Abstract] [Full Text] [Related]
3. Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy. Weber LT, Shipkova M, Armstrong VW, Wagner N, Schütz E, Mehls O, Zimmerhackl LB, Oellerich M, Tönshoff B. Clin Chem; 2002 Mar; 48(3):517-25. PubMed ID: 11861442 [Abstract] [Full Text] [Related]
5. Evaluation of the EMIT Mycophenolic Acid Assay from Dade Behring. Vogl M, Weigel G, Seebacher G, Griesmacher A, Laufer G, Müller MM. Ther Drug Monit; 1999 Dec; 21(6):638-43. PubMed ID: 10604825 [Abstract] [Full Text] [Related]
6. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients. Kunicki PK, Pawiński T, Boczek A, Waś J, Bodnar-Broniarczyk M. Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305 [Abstract] [Full Text] [Related]
7. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Prémaud A, Rousseau A, Le Meur Y, Lachâtre G, Marquet P. Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184 [Abstract] [Full Text] [Related]
11. Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients. Irtan S, Azougagh S, Monchaud C, Popon M, Baudouin V, Jacqz-Aigrain E. Pediatr Nephrol; 2008 Oct; 23(10):1859-65. PubMed ID: 18594872 [Abstract] [Full Text] [Related]
12. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay. Shipkova M, Schütz E, Besenthal I, Fraunberger P, Wieland E. Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920 [Abstract] [Full Text] [Related]
13. Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients. Chen B, Gu Z, Chen H, Zhang W, Fen X, Cai W, Fan Q. Ther Drug Monit; 2010 Oct; 32(5):653-60. PubMed ID: 20814351 [Abstract] [Full Text] [Related]
18. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Weber LT, Lamersdorf T, Shipkova M, Niedmann PD, Wiesel M, Zimmerhackl LB, Staskewitz A, Schütz E, Mehls O, Oellerich M, Armstrong VW, Tönshoff B. Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445 [Abstract] [Full Text] [Related]
19. The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers. Dias VC, Legatt DF, Yatscoff RW. Clin Biochem; 1997 Mar; 30(2):155-62. PubMed ID: 9127698 [Abstract] [Full Text] [Related]